PI
MLAB icon

Putnam Investments’s Mesa Laboratories MLAB Stock Holding History

Putnam Investments’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,328
Closed -$3.29M – 1167
2022
Q3 		$3.29M Sell
23,328
-5,685
-20% -$1.04M 0.01% 567
2022
Q2 		$5.92M Buy
29,013
+587
+2% +$129K 0.01% 398
2022
Q1 		$7.25M Sell
28,426
-143
-0.5% -$38.8K 0.01% 415
2021
Q4 		$9.37M Buy
28,569
+1,612
+6% +$506K 0.01% 386
2021
Q3 		$8.15M Sell
26,957
-33
-0.1% -$9.38K 0.01% 415
2021
Q2 		$7.32M Buy
26,990
+227
+0.8% +$57.6K 0.01% 439
2021
Q1 		$6.52M Buy
26,763
+165
+0.6% +$45.4K 0.01% 451
2020
Q4 		$7.62M Buy
26,598
+131
+0.5% +$36K 0.01% 423
2020
Q3 		$6.74M Sell
26,467
-12,059
-31% -$2.87M 0.01% 416
2020
Q2 		$8.35M Buy
38,526
+6,011
+18% +$1.39M 0.02% 358
2020
Q1 		$7.35M Buy
32,515
+4,578
+16% +$1.13M 0.02% 369
2019
Q4 		$6.97M Buy
27,937
+7,587
+37% +$1.78M 0.01% 448
2019
Q3 		$4.84M Buy
+20,350
New +$4.7M 0.01% 517

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Putnam Investments's MLAB Position: Q4 2022 in Review

Putnam Investments sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 23,328 shares — an estimated $3.29M sold.

Putnam Investments first reported a position in MLAB in Q3 2019 and held it in 13 quarters. The position peaked at $9.37M in Q4 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

  • Putnam Investments reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
  • Putnam Investments sold 23,328 Mesa Laboratories shares in Q4 2022, an estimated $3.29M.
  • Putnam Investments first reported a position in Mesa Laboratories in Q3 2019 and held it in 13 quarters.
  • Putnam Investments's Mesa Laboratories position peaked at $9.37M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.